HAIER BIOMEDICAL(SH:688139) Sou Hu Cai Jing·2025-08-11 11:57Group 1 - The core viewpoint of the news highlights Haier Biomedical's stock performance, with a closing price of 34.33 yuan, an increase of 2.85%, and a rolling PE ratio of 32.17, marking a new low in 88 days, with a total market value of 10.915 billion yuan [1] - As of March 31, 2025, Haier Biomedical has 12,793 shareholders, a decrease of 453 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Haier Biomedical focuses on providing comprehensive digital solutions for life sciences and healthcare, targeting pharmaceutical companies, research institutions, hospitals, and public health organizations [2] - The company offers a wide range of products including low-temperature storage boxes, automated biological sample storage libraries, and various laboratory automation equipment, enhancing its innovation capabilities in life sciences and medical fields [2] - In 2022, Haier Biomedical received several prestigious awards and certifications, including the National Postdoctoral Research Workstation and the China Industrial Award, reflecting its growing strength in scientific and technological innovation [2] Group 3 - In the latest quarterly report for Q1 2025, Haier Biomedical reported an operating income of 689 million yuan, a year-on-year increase of 0.30%, and a net profit of 110 million yuan, a year-on-year decrease of 19.88%, with a gross profit margin of 48.35% [3] - The company ranks 63rd in the medical device industry based on its PE ratio, which is significantly lower than the industry average of 56.56 and the median of 39.76 [3]